PBS Biotech is a leading provider of single-use bioreactor systems and process development services for the global allogenic cell therapy market. With headquarters in Camarillo, California, the company offers scalable solutions to streamline process development and accelerate time to market for cell therapy manufacturers. Their Vertical-Wheel bioreactor technology is specifically optimized for applications involving induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), offering superior mixing performance and scalability compared to traditional stirred-tank bioreactors.

In addition to their innovative products, PBS Biotech's Bioprocess Research & Development team provides world-class contract process development services, utilizing their state-of-the-art onsite laboratory. The company's 63,800 sq. With recent substantial funding, PBS Biotech is poised to enhance their product portfolio and expand support for a global customer base.

Their vision is to establish themselves as the worldwide standard manufacturing platform for allogenic cell-based therapies, facilitating potential cures for serious indications such as diabetes, cancer, and heart disease